BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 25509245)

  • 21. Haemovigilance in a general university hospital: need for a more comprehensive classification and a codification of transfusion-related events.
    Siegenthaler MA; Schneider P; Vu DH; Tissot JD
    Vox Sang; 2005 Jan; 88(1):22-30. PubMed ID: 15663719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of blood transfusion product type and amount in deep vein thrombosis after cardiac surgery.
    Ghazi L; Schwann TA; Engoren MC; Habib RH
    Thromb Res; 2015 Dec; 136(6):1204-10. PubMed ID: 26553018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multistate cluster of red blood cell transfusion reactions associated with use of a leucocyte reduction filter.
    Alvarado-Ramy F; Kuehnert MJ; Alonso-Echanove J; Sledge L; Haley NR; Epstein J; Vostal J; Pearson M
    Transfus Med; 2006 Feb; 16(1):41-8. PubMed ID: 16480438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors related to transfusion requirements in patients undergoing implantation of ventricular assist devices.
    Neill S; Engoren M; Kouatli Y; Shields TA; Jewell E; Pagani FD
    J Cardiothorac Vasc Anesth; 2015 Apr; 29(2):297-302. PubMed ID: 25488077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfusion protocol for implantation and explantation of cardiac devices in an academic medical center.
    Bartley AN; Redford DT; Berg MP
    ASAIO J; 2007; 53(3):320-3. PubMed ID: 17515722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risks associated with the transfusion of various blood products in aortic valve replacement.
    Bjursten H; Al-Rashidi F; Dardashti A; Brondén B; Algotsson L; Ederoth P
    Ann Thorac Surg; 2013 Aug; 96(2):494-9. PubMed ID: 23816419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demographic and epidemiologic characterization of transfusion recipients from four US regions: evidence from the REDS-III recipient database.
    Karafin MS; Bruhn R; Westlake M; Sullivan MT; Bialkowski W; Edgren G; Roubinian NH; Hauser RG; Kor DJ; Fleischmann D; Gottschall JL; Murphy EL; Triulzi DJ;
    Transfusion; 2017 Dec; 57(12):2903-2913. PubMed ID: 29067705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An approach to prevent the severe adverse events associated with transfusion of FDA-approved blood products.
    Valeri CR; Ragno G
    Transfus Apher Sci; 2010 Jun; 42(3):223-33. PubMed ID: 20392670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors related to allergic transfusion reactions and febrile non-haemolytic transfusion reactions in children.
    Yanagisawa R; Shimodaira S; Sakashita K; Hidaka Y; Kojima S; Nishijima F; Hidaka E; Shiohara M; Nakamura T
    Vox Sang; 2016 May; 110(4):376-84. PubMed ID: 26808840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC.
    Yazer MH; Podlosky L; Clarke G; Nahirniak SM
    Transfusion; 2004 Jan; 44(1):10-5. PubMed ID: 14692961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of allogeneic blood transfusions on clinical outcomes in severely burned patients.
    Kaserer A; Rössler J; Slankamenac K; Arvanitakis M; Spahn DR; Giovanoli P; Steiger P; Plock JA
    Burns; 2020 Aug; 46(5):1083-1090. PubMed ID: 31866181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An audit of reported acute transfusion reactions in Universiti Kebangsaan Malaysia Medical Centre.
    Rabeya Y; Abdul-Kahar AH; Leong CF
    Malays J Pathol; 2011 Jun; 33(1):25-9. PubMed ID: 21874748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraoperative blood product resuscitation and mortality in ruptured abdominal aortic aneurysm.
    Kauvar DS; Sarfati MR; Kraiss LW
    J Vasc Surg; 2012 Mar; 55(3):688-92. PubMed ID: 22277689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute transfusion reactions.
    Henderson RA; Pinder L
    N Z Med J; 1990 Oct; 103(900):509-11. PubMed ID: 2234645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ongoing variability in blood transfusion practices in cardiac surgery.
    Snyder-Ramos SA; Möhnle P; Weng YS; Böttiger BW; Kulier A; Levin J; Mangano DT; ;
    Transfusion; 2008 Jul; 48(7):1284-99. PubMed ID: 18422857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective evaluation of the indications, safety and effects of fresh frozen plasma transfusions in 36 cats (2014-2018).
    Mansi ET; Waldrop JE; Davidow EB
    J Feline Med Surg; 2020 Aug; 22(8):696-704. PubMed ID: 31576775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood collection and transfusion in the United States in 1999.
    Sullivan MT; Wallace EL
    Transfusion; 2005 Feb; 45(2):141-8. PubMed ID: 15660821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical use of blood products in cats: a retrospective study (1997--2000).
    Castellanos I; Couto CG; Gray TL
    J Vet Intern Med; 2004; 18(4):529-32. PubMed ID: 15320592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood transfusion practice in Belgium. As assessed by a national survey.
    Beguin C; Lambermont M; Dupont E; Vandermeersch E; France FH; Waterloos H; Baele P
    Acta Anaesthesiol Belg; 1998; 49(2):141-52. PubMed ID: 9675384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of fresh frozen plasma usage at the University Hospital Center Rijeka.
    Balen S; Caser L; Ivanković E; Samardzija M; Ivanković Z; Vcev A
    Coll Antropol; 2009 Dec; 33(4):1375-81. PubMed ID: 20102096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.